TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,200 | -22.7% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $28,723 | +1.2% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $28,388 | -5.1% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $29,898 | -6.6% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $32,000 | -13.5% | 30,200 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $37,000 | +15.6% | 30,200 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $32,000 | -25.6% | 30,200 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $43,000 | -33.8% | 30,200 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $65,000 | -26.1% | 30,200 | +0.7% | 0.01% | -25.0% |
| Q2 2021 | $88,000 | -22.1% | 30,000 | 0.0% | 0.01% | -27.3% |
| Q1 2021 | $113,000 | -0.9% | 30,000 | 0.0% | 0.01% | -15.4% |
| Q4 2020 | $114,000 | +103.6% | 30,000 | +7.5% | 0.01% | +85.7% |
| Q3 2020 | $56,000 | +27.3% | 27,900 | +39.5% | 0.01% | +16.7% |
| Q2 2020 | $44,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 657,100 | $11,072,000 | 4.49% |
| GOLDMAN CAPITAL MANAGEMENT INC | 343,000 | $5,780,000 | 3.30% |
| Lyon Street Capital, LLC | 368,858 | $6,215,257,000 | 3.08% |
| JAY JEFFREY R | 163,140 | $2,749,000 | 2.17% |
| Adirondack Research & Management Inc. | 161,507 | $2,721,000 | 2.03% |
| Park West Asset Management LLC | 448,415 | $7,556,000 | 0.89% |
| Benchmark Capital Advisors | 51,600 | $869,000 | 0.67% |
| SHEPHERD KAPLAN KROCHUK, LLC | 166,034 | $2,797,000 | 0.55% |
| HEARTLAND ADVISORS INC | 1,569,699 | $26,449,000 | 0.49% |
| WOODMONT INVESTMENT COUNSEL LLC | 86,682 | $1,461,000 | 0.49% |